The main inspiration for creation of this work was from the book by Gabrielsson and Weiner [1] . Authors of chapter "PK 2 -One compartment oral data" (pages 333-340) aimed at the modeling of oral administered substance A using one compartment model presented first order input model known as Bateman function with a lag time [2] [3] [4] [5] [6] . Parameter estimation by WinNonlin version 1.1 (Scientific Consulting Inc., Apex, NC) were performed.
Bateman function in fig. 1 presents a concave function on the interval 0-100 min, but it does not satisfactorily describe the measured points on the interval 40-100 min (dashed line in fig. 1 ). Our working hypothesis for the explanation of the pseudolinear phenomena -plateau was that the atypical shape of the measured profile on the interval 40-100 min is caused by the gastrointestinal (GI) and the circulation system. Glucose is used as second example with the atypical shape of the measured concentration profile on the interval 15-30 min. There are also other examples of the atypical shape of the concentration-time profile of oral administered drug, such as L-arginine [7] , vitamin C [8] , ibuprofen [9] , fenobam [10] , paracetamol [11] and anthocyanins [12] .
MATERIALS AND METHODS
A human volunteer was given a single oral dose comprising 100 µg of substance A. Consequently, the frequent sampling to obtain the concentration-time data was done at 10, 15, 20, 30, 40, 60, 90, 120, 180, 210, 240, 300, and 360 min after substance A administration [1] . Two other human volunteers (one male and one female) were given 75 g of anhydrous glucose [13] in 250 ml water solution within 1-2 min at time zero. Approval of the study protocol Research Paper was obtained from the Ethic Committee of the Institute of Experimental Endocrinology of Slovak Academy of Sciences [13] . Frequent sampling oral glucose tolerance test was performed by the criteria of Expert Committee on Diagnosis and Classification of Diabetes Mellitus [14] . The blood samples were collected at 15 min before the glucose was administered and at 8, 15, 22, 30, 45, 60, 90, 120, 140, 160 , and 180 min after the glucose was administered. Determination of glucose plasma concentrations was carried out by using the glucose oxidize method (Boehringer Manheim, Germany) [13] .
Structural model construction:
Inclusion of the GI system to the hemodynamic circulatory model ( fig. 2) gives the option to analyze the plateau phenomena on the measured concentration-time profile shown in fig. 1 . The scheme of the proposed structural model, with the oral substance dose D as input and the substance blood concentration in the sampling subsystem C S as output, includes the cardiopulmonary subsystem CP, the portal subsystem P, the liver subsystem L, the GI subsystem, the other subsystems O and the sampling subsystem S. Assuming that all of the significant subsystems shown in fig. 2 within the range of measured concentrations formalized behave as linear dynamic systems, then i th subsystem can be described by the transfer function H i presented the general mathematical model of the subsystem as well-stirred model with time delay:
where s is Laplace operator, T is time constant of the subsystem and τ is time delay of the subsystem. The constant g i represented the attenuation of the subsystem and quantified the uptake of substance A in specific subsystem is expressed by the form:
The definition and the transfer function of the GI subsystem comprising absorption part A and gastric empting (GE) ( fig. 3 ) and respecting the mass balance is defined as absorbed amount per unit of time in GI subsystem in the first-pass metabolism of the drug, T A is mean residence time of the absorption subsystem, F is fraction and τ is time delay of the subsystem.
For substance blood concentration in the right atrium C RA is valid
where Q CP is plasmatic blood flow through CP system expressed as follows: The definitions and transfer functions of the elementary subsystems, respecting the mass balance, are considered as follows equations:
Regarding the CP subsystem is valid
where C LV is the substance concentration in the left ventricle, M RA is the substance amount per unit of time in the right atrium and Q CP is plasmatic blood flow via CP subsystem.
Regarding the portal subsystem P is valid
where M P , g P , Q P , G P and T P are the substance amount per unit of time, the attenuation, the plasmatic blood flow, the gain and the time constant, respectively, related to the portal subsystem.
Regarding the liver subsystem L is valid
where M Hv is the substance amount per unit of time in the hepatic vein. M L , g L and T L are the substance amount per unit of time, the attenuation and the time constant, respectively, related to the liver subsystem, where g L is dimensionless value.
Regarding the other organ subsystem O is valid The model of peripheral sampling subsystem S was considered as ideal subsystem for which is valid
For the mean residence time of the drug in the whole body (MRT W ) after the oral administration is valid following equation:
and for the mean residence time of the GI subsystem (MRT GI ) is valid The elimination rate constant k el is expressed as
where C S is the concentration of the substance in the sampling subsystem S.
All model calculation and parameter estimation using the Clinical Trials DataBase software [15] were performed. Employing the parameters of the developed structural mathematical model (figs. 2 and 3), the vector λ of estimated parameters was determined as follows:
The point estimate the model parameters by the Monte Carlo method [16] implemented in Computer Controlled Sequential Simulation method [17, 18] .
RESULTS AND DISCUSSION
The final outcome of the processed data obtained from the human volunteer is presented in fig. 4 (substance A), 5-6 (glucose) and Tables 1-3. Figs. 4 and 5 show the measured and modeled concentration-time profile C of substance A and glucose 1 and the influence of the first absorbed fraction F 1 and the second absorbed fraction F 2 . The absorbed fractions F 1 and F 2 expressed by partial concentration-time profiles C 1 (dashed line) and C 2 (dotted line), respectively, are responsible for the main peak 1 of the final concentration-time profile C and presents the result of the effect of gastric emptying. The final shape of the concentration-time profile C for t≤60 min is expressed as:
where C 1 and C 2 are the partial concentration-time profiles developed by fraction F 1 and F 2 , respectively. Consequently, the secondary peak 2 is the time transformed peak 1 probably influenced by the deep compartment and the circulation system. Fig. 6 shows the measured and modeled concentration-time profile of glucose 2. In comparison with concentration-time profile of glucose 1 and substance A, concentration-time profile glucose 2 comprises only one absorbed fraction.
The model estimated parameters of the GI and the circulation subsystems are listed in Tables 1 and 2 , respectively. The model parameters of the GI subsystem include absorbed fractions F 1 and F 2 , time delays τ 1 and τ 2 , mean residence time of the absorption subsystem T A and MRT GI . Obtained results of the model approximation show approximately twice more value of the second fraction contrary to the first fraction ( Table 1) .
The model parameters of the circulation subsystem include plasmatic blood flow in the CP subsystem Q CP , gain of the liver, portal, and the other organ subsystems as G L , G P, and G O , respectively, time delay of the other subsystem τ O , mean residence time of the liver, portal, and the other organ subsystems as T L , T P, and T O , respectively, and MRT CIRC are listed in Table 2 .
The comparison between derived or estimated parameters by our developed hemodynamic circulatory model and parameters estimated by using the Bateman function is listed in Table 3 .
Our work as a reanalysis of the study of Gabrielsson and Weiner [1] , was focused on the identification of the system defined by the oral administered substance A and frequent sampling oral glucose tolerance test data as the input and the measured concentration-time profile as the output by hemodynamic circulatory structural model included GI subsystem. This is for the substances with high coefficient of absorption.
While one compartment open model (Bateman function) was not capable of fitting the measured data within the time interval 40-100 min ( fig. 1) in case of substance A and the time interval 15-30 min in case of glucose, our model approximation presents a good fitting of the measured values within this interval (figs. [4] [5] [6] . The shape of final concentration-time profile C as the result of the parameters estimation by our structural model is characterized by the individual peaks 1 and 2. Regarding obtained results of our modeling, the peak 1 is expressed by the sum of the partial concentration-time profiles C 1 and C 2 related to the individual absorbed fractions F 1 and F 2 , respectively, which suggest the effect of the GI system. The second peak 2 presents the influence mainly of the circulation system included the deep compartment to the final concentration-time profile of substance A in the observed human subject. In Table 1 , the first fraction F 1 (34.425% -substance A) and (33% -glucose 1) was absorbed in the small intestine with the time delay of 11.579 min (substance A) and 1.731 min (glucose 1) compared to the second absorbed fraction F 2 (65.575% -substance A) and (66% -glucose 1) with the time delay of 27.262 min (substance A) and 13.398 min (glucose 1). = , where C in is the input substance concentration to the system and C out is the output substance concentration from the system, characterizes the substance uptake in the liver subsystem. In the case of C (Table 2 ) then indicates the uptake of the substance A in the liver. The uptake of the glucose in the liver is 0.229 (glucose 1) and 1.022 (glucose 2). Table 3 shows to the comparison between the individual absorption k a and elimination k el rate constants. Absorption rate constant k a * according to study [1] of 0.043 l/min appears 2 times higher values in comparison with our estimated value k a of 0.022 l/min. The elimination rate constant k el * (0.009 l/min) according to study [1] presents similar values compared to calculations (Eq. 2) related to our developed structural model (0.008 l/min and 0.295 l/min, respectively). The value of mean residence time MRT W of the whole body calculated by our structural model was 130.646 min (substance A), 38.756 min (glucose 1) and 43.067 (glucose 2). Model estimated value of k a for glucose 1 is 0.35, which is similar to the value estimated by Bateman function (0.47) and for glucose 2 is 0.922 is 3 times higher as compared to the value estimated by using Bateman function (0.365). Model estimated values k e for glucose 1 and 2 are 0.41 and 0.39, respectively and they are very similar to the values estimated by using Bateman function (Table 2 ).
In summary, obtained model results show a good approximation of the final concentration-time profile of substance A and glucose by our hemodynamic circulatory structural model compared to the Bateman function. Our work presents the validation of the hypothesis that the atypical shape of measured concentration-time profile of oral administered substance A and glucose single dose was due to the effect of the GI subsystem and the circulation system included the deep compartment.
